Welcome to LookChem.com Sign In|Join Free

CAS

  • or

52079-10-4

Post Buying Request

52079-10-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

52079-10-4 Usage

Description

O-DESMETHYLNAPROXEN, a member of the class of naphthols, is a chemical compound derived from naproxen by demethylation of the 6-methoxy group. It is characterized by its off-white to pale pink solid appearance and is known for its pharmaceutical applications.

Uses

Used in Pharmaceutical Industry:
O-DESMETHYLNAPROXEN is used as an intermediate compound for the synthesis of naproxen and its derivatives. It plays a crucial role in the development of anti-inflammatory and analgesic medications.
Used in Research and Development:
O-DESMETHYLNAPROXEN is used as a research tool for assaying naproxen metabolites. This application aids in understanding the metabolic pathways and pharmacokinetics of naproxen, which is essential for optimizing its therapeutic use and minimizing potential side effects.

Biochem/physiol Actions

CYP2C9 metabolite of naproxen

Check Digit Verification of cas no

The CAS Registry Mumber 52079-10-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,2,0,7 and 9 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 52079-10:
(7*5)+(6*2)+(5*0)+(4*7)+(3*9)+(2*1)+(1*0)=104
104 % 10 = 4
So 52079-10-4 is a valid CAS Registry Number.
InChI:InChI=1/C12H10O3.CH4/c13-11-4-3-9-5-8(6-12(14)15)1-2-10(9)7-11;/h1-5,7,13H,6H2,(H,14,15);1H4

52079-10-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Sigma

  • (UC305)  O-Desmethylnaproxen  

  • 52079-10-4

  • UC305-5MG

  • 4,089.15CNY

  • Detail
  • Sigma

  • (UC305)  O-Desmethylnaproxen  

  • 52079-10-4

  • UC305-10MG

  • 7,347.60CNY

  • Detail
  • Sigma-Aldrich

  • (95114)  O-Desmethylnaproxen  analytical standard

  • 52079-10-4

  • 95114-25MG

  • 1,769.04CNY

  • Detail

52079-10-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name O-Desmethylnaproxen

1.2 Other means of identification

Product number -
Other names (2S)-2-(6-hydroxynaphthalen-2-yl)propanoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:52079-10-4 SDS

52079-10-4Relevant articles and documents

Discovery of (R)-2-(6-Methoxynaphthalen-2-yl)butanoic Acid as a Potent and Selective Aldo-keto Reductase 1C3 Inhibitor

Adeniji, Adegoke,Uddin, Md. Jashim,Zang, Tianzhu,Tamae, Daniel,Wangtrakuldee, Phumvadee,Marnett, Lawrence J.,Penning, Trevor M.

, p. 7431 - 7444 (2016)

Type 5 17β-hydroxysteroid dehydrogenase, aldo-keto reductase 1C3 (AKR1C3) converts Δ4-androstene-3,17-dione and 5α-androstane-3,17-dione to testosterone (T) and 5α-dihydrotestosterone, respectively, in castration resistant prostate cancer (CRPC). In CRPC, AKR1C3 is implicated in drug resistance, and enzalutamide drug resistance can be surmounted by indomethacin a potent inhibitor of AKR1C3. We examined a series of naproxen analogues and find that (R)-2-(6-methoxynaphthalen-2-yl)butanoic acid (in which the methyl group of R-naproxen was replaced by an ethyl group) acts as a potent AKR1C3 inhibitor that displays selectivity for AKR1C3 over other AKR1C enzymes. This compound was devoid of inhibitory activity on COX isozymes and blocked AKR1C3 mediated production of T and induction of PSA in LNCaP-AKR1C3 cells as a model of a CRPC cell line. R-Profens are substrate selective COX-2 inhibitors and block the oxygenation of endocannabinoids and in the context of advanced prostate cancer R-profens could inhibit intratumoral androgen synthesis and act as analgesics for metastatic disease.

Efficient demethylation of aromatic methyl ethers with HCl in water

Bomon, Jeroen,Bal, Mathias,Achar, Tapas Kumar,Sergeyev, Sergey,Wu, Xian,Wambacq, Ben,Lemière, Filip,Sels, Bert F.,Maes, Bert U. W.

supporting information, p. 1995 - 2009 (2021/03/26)

A green, efficient and cheap demethylation reaction of aromatic methyl ethers with mineral acid (HCl or H2SO4) as a catalyst in high temperature pressurized water provided the corresponding aromatic alcohols (phenols, catechols, pyrogallols) in high yield. 4-Propylguaiacol was chosen as a model, given the various applications of the 4-propylcatechol reaction product. This demethylation reaction could be easily scaled and biorenewable 4-propylguaiacol from wood and clove oil could also be applied as a feedstock. Greenness of the developed methodversusstate-of-the-art demethylation reactions was assessed by performing a quantitative and qualitative Green Metrics analysis. Versatility of the method was shown on a variety of aromatic methyl ethers containing (biorenewable) substrates, yielding up to 99% of the corresponding aromatic alcohols, in most cases just requiring simple extraction as work-up.

Peptide-Catalyzed Fragment Couplings that Form Axially Chiral Non-C2-Symmetric Biaryls

Coombs, Gavin,Sak, Marcus H.,Miller, Scott J.

supporting information, p. 2875 - 2880 (2020/01/24)

We have demonstrated that small, modular, tetrameric peptides featuring the Lewis-basic residue β-dimethylaminoalanine (Dmaa) are capable of atroposelectively coupling naphthols and ester-bearing quinones to yield non-C2-symmetric BINOL-type scaffolds with good yields and enantioselectivity. The study culminates in the asymmetric synthesis of backbone-substituted scaffolds similar to 3,3′-disubstituted BINOLs, such as (R)-TRIP, with good (94:6 e.r.) to excellent (>99.9:0.1 e.r.) enantioselectivity after recrystallization, and a diastereoselective net arylation of the minimally modified nonsteroidal anti-inflammatory drug (NSAID) naproxen.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 52079-10-4